Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary ...
Business Wire18 天
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced ...
Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ ...